Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II …
SZ Goldhaber, H Eriksson, A Kakkar… - Vascular …, 2016 - journals.sagepub.com
It is unclear whether thrombophilia causes resistance to anticoagulant therapy. Post hoc
analyses of data from RE-COVER®, RE-COVER™ II, and RE-MEDY™ were performed to …
analyses of data from RE-COVER®, RE-COVER™ II, and RE-MEDY™ were performed to …
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II …
SZ Goldhaber, H Eriksson, A Kakkar… - Vascular Medicine …, 2016 - europepmc.org
It is unclear whether thrombophilia causes resistance to anticoagulant therapy. Post hoc
analyses of data from RE-COVER®, RE-COVER™ II, and RE-MEDY™ were performed to …
analyses of data from RE-COVER®, RE-COVER™ II, and RE-MEDY™ were performed to …
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II …
SZ Goldhaber, H Eriksson, A Kakkar… - Vascular …, 2016 - search.ebscohost.com
It is unclear whether thrombophilia causes resistance to anticoagulant therapy. Post hoc
analyses of data from RE-COVER< sup>®, RE-COVER< sup>™ II, and RE-MEDY< sup>™ …
analyses of data from RE-COVER< sup>®, RE-COVER< sup>™ II, and RE-MEDY< sup>™ …
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER ® , RE-COVER™ II …
SZ Goldhaber, H Eriksson, A Kakkar, S Schellong… - Vascular …, 2016 - elibrary.ru
It is unclear whether thrombophilia causes resistance to anticoagulant therapy. Post hoc
analyses of data from RE-COVER (R), RE-COVER II, and RE-MEDY were performed to …
analyses of data from RE-COVER (R), RE-COVER II, and RE-MEDY were performed to …
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II …
SZ Goldhaber, H Eriksson, A Kakkar… - Vascular medicine …, 2016 - pubmed.ncbi.nlm.nih.gov
It is unclear whether thrombophilia causes resistance to anticoagulant therapy. Post hoc
analyses of data from RE-COVER®, RE-COVER™ II, and RE-MEDY™ were performed to …
analyses of data from RE-COVER®, RE-COVER™ II, and RE-MEDY™ were performed to …
[PDF][PDF] Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE …
SZ Goldhaber, H Eriksson, A Kakkar, S Schellong… - Vascular …, 2016 - academia.edu
It is unclear whether thrombophilia causes resistance to anticoagulant therapy. Post hoc
analyses of data from RECOVER®, RE-COVER™ II, and RE-MEDY™ were performed to …
analyses of data from RECOVER®, RE-COVER™ II, and RE-MEDY™ were performed to …
[PDF][PDF] Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE …
SZ Goldhaber, H Eriksson, A Kakkar, S Schellong… - Vascular …, 2016 - academia.edu
It is unclear whether thrombophilia causes resistance to anticoagulant therapy. Post hoc
analyses of data from RECOVER®, RE-COVER™ II, and RE-MEDY™ were performed to …
analyses of data from RECOVER®, RE-COVER™ II, and RE-MEDY™ were performed to …